UBS AM’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.22M | Buy |
161,490
+11,972
| +8% | +$609K | ﹤0.01% | 1455 |
|
|
2025
Q1 | $6.74M | Buy |
149,518
+75,630
| +102% | +$3.41M | ﹤0.01% | 1410 |
|
|
2024
Q4 | $3.06M | Buy |
73,888
+10,427
| +16% | +$431K | ﹤0.01% | 1842 |
|
|
2024
Q3 | $2.47M | Buy |
63,461
+3,442
| +6% | +$134K | ﹤0.01% | 1931 |
|
|
2024
Q2 | $2.05M | Buy |
60,019
+18,914
| +46% | +$647K | ﹤0.01% | 1984 |
|
|
2024
Q1 | $1.03M | Buy |
41,105
+300
| +0.7% | +$7.54K | ﹤0.01% | 1998 |
|
|
2023
Q4 | $1.2M | Buy |
40,805
+1,995
| +5% | +$58.9K | ﹤0.01% | 1926 |
|
|
2023
Q3 | $1.23M | Buy |
38,810
+15,961
| +70% | +$504K | ﹤0.01% | 1849 |
|
|
2023
Q2 | $549K | Hold |
22,849
| – | – | ﹤0.01% | 2283 |
|
|
2023
Q1 | $549K | Buy |
22,849
+2,685
| +13% | +$64.5K | ﹤0.01% | 2283 |
|
|
2022
Q4 | $393K | Buy |
+20,164
| New | +$393K | ﹤0.01% | 2265 |
|